Yinghai Xie

发表

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

D. Ma, Xiaolong Tang, Shuping Zhou, 2019, American journal of translational research.

BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.

Xiaolong Tang, Shuping Zhou, Xinkuang Liu, 2019, American journal of translational research.

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Xiaolong Tang, Binquan Wu, Rongbo Zhang, 2019, American journal of translational research.

The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway

Xudong Huang, D. Ma, Xiaolong Tang, 2020, Nanoscale Research Letters.

ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway

Xiaolong Tang, Shuping Zhou, Yinci Zhang, 2022, BMC Cancer.

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Lingling Song, Xiaolong Tang, Shuping Zhou, 2020, International journal of medical sciences.

Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.

Xiang-ling Meng, Jun Song, Yong Yang, 2015, Hepato-gastroenterology.

BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy

Lingling Song, Xiaolong Tang, Shuping Zhou, 2021, BioMed research international.

PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair

Qi Wang, Changwei Liu, Amin Li, 2021, PloS one.

ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals

Xiaolong Tang, Shuping Zhou, Yinci Zhang, 2022, Journal of cellular and molecular medicine.

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway

Lingling Song, Xiaolong Tang, Shuping Zhou, 2021, Molecular medicine reports.

The Functions and Technical Design of Chinese Internet Hospitals (Preprint)

Yinghai Xie, Zhuhua Jin, Lixin Yang, 2021 .